Get your Emails warmed up and ready to send
Build sender reputation and reach more inboxes with automated email warmup.
Warm up your emails
Starting at $49/month
Yaniv Erlich
Chief Executive Officer @Eleven Therapeutics
Signup · Get unlimited contacts
WORK HISTORY
Chief Executive Officer @Eleven Therapeutics
Tel Aviv, IL
EDUCATION
Tel Aviv University
Bachelor of Science (BSc), Computational Neuroscience, Summa cum laude
Cold Spring Harbor Laboratory
Doctor of Philosophy (PhD), Genomics
ABOUT YANIV ERLICH
Prof. Yaniv Erlich is the CEO and co-founder of Eleven Therapeutics. Prior to this postion, he was the CSO of MyHeritage (acquired by Francisco Partners). Before moving to the biotech industry, Prof. Erlich was an Associate Professor of Computer Science at Columbia University and was a PI at the Whitehead Institute, MIT. Prof. Erlich received his bachelor’s degree (summa cum laude from) Tel-Aviv University, Israel (2006) and a PhD from the Watson School of Biological Sciences at Cold Spring Harbor Laboratory (2010). Prof. Erlich authored over 50 peer-reviewed scientific studies and patents, including multiple papers in Science, Nature Genetics, Nature Biotechnology, and Nature Methods, all as a senior author. Prof. Erlich is a TEDMED speaker (2018), the recipient of DARPA’s Young Faculty Award (2017), the Burroughs Wellcome Career Award (2013), Harold M. Weintraub award (2010), the HPC award (2008), and he was selected as one of 2010 Tomorrow’s PIs team of Genome Technology.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.